Large And Small, These Biotech Stocks Could Be Big Winners
One large-cap biotech and two small-cap biotechs – one which “has been content with staying out of the limelight” and a second, higher-risk play –…
One large-cap biotech and two small-cap biotechs – one which “has been content with staying out of the limelight” and a second, higher-risk play –…
“With the scramble for viral and antibody testing kits, and the ultimate goal of finding a vaccine for Covid-19, many biotech companies are suddenly in…
In a bullish take on current circumstances, Morgan Stanley’s head of U.S. equity strategy argued in a recent note to clients that the current state…
Heightened volatility across most asset classes over the last two months has led to a surge in trading volumes – and to exchange stocks (the…
If you need any further evidence of just how much the COVID-19 pandemic has increased the allure of biotechnology stocks, consider the little-known Chinese biotech…
This clinical-stage biopharmaceutical company focused on developing treatments for different kinds of cancers just recently launched an IPO, making it just the second IPO to…
As testing for COVID-19 in the U.S. (or lack thereof) has been a much-discussed topic over the past month, shares of one diagnostics and pharmaceutical…
While some are clearly being hit harder than others, every sector is being impacted to some extent by the widespread disruptions caused by the coronavirus…
In recent days, the stock market has experienced both its worst – and best – days in decades, leading the author of today’s article to…
Sustainable investing has gone from niche to mainstream – and a number of the sustainable companies highlighted in today’s article put an emphasis on sustainability…